Follow The Filings

INMB INmune Bio

INmune Bio earnings company data as of 7:58 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 29 Oct EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by INMB's executives, directors and 10% owners in the last 12 months, from their Form 4s

All INMB insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales

No open-market buys or sales on file.

Also filed in the last 12 months, not counted as buying or selling: 3 option exercises.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 7.01,8.01,9.01 Filing Doc
8-K 5.02,8.01,9.01 Filing Doc
10-Q QUARTERLY REPORT Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 1.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
10-Q QUARTERLY REPORT Filing Doc
8-K 1.01,7.01,9.01 Filing Doc
DEF 14A PROXY STATEMENT Filing Doc
10-K ANNUAL REPORT Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 1.01,9.01 Filing Doc
424B5 PROSPECTUS SUPPLEMENT Filing Doc
8-K 1.01,9.01 Filing Doc
8-K 1.02 Filing Doc
8-K 1.01,3.03,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 2 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.